Home › Funds › Vivo Capital, LLC › OLMA

Vivo Capital, LLC position in OLMA

OLEMA PHARMACEUTICALS INC · Health Care

Vivo Capital, LLC reported holding 671,843 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 0.66% of its reported portfolio and ranking #34 among its reported holdings. Vivo Capital, LLC has disclosed OLMA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)671.84K sh
Reported value held$5.80M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's OLMA position evolved

Vivo Capital, LLC first disclosed a stake in OLMA in Q3 2023 at 1,873,704 shares (US$23.1M). The position peaked in Q4 2023 at 1,873,704 shares, worth US$26.3M. Across 13 filings, Vivo Capital, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 671,843 shares valued at US$5.8M. Notable position changes include a 55% trim in Q4 2025 (shares fell 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.87M $23.14M New
Q4 2023 1.87M $26.29M Hold
Q1 2024 1.87M $21.21M Hold
Q2 2024 1.87M $20.27M Hold
Q3 2024 1.51M $17.98M Reduce
Q4 2024 1.51M $8.78M Hold
Q1 2025 1.51M $5.66M Hold
Q2 2025 1.51M $6.41M Hold
Q3 2025 1.51M $14.74M Hold
Q4 2025 671.84K $16.80M Reduce
Q1 2026 671.84K $10.02M Hold
Q2 2026 671.84K $8.40M Hold
Q3 2026 671.84K $5.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OLMA and 13F data

OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OLMA

All OLMA fund holders →

FAQ

How long has Vivo Capital, LLC held OLMA?

Vivo Capital, LLC has disclosed OLMA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Vivo Capital, LLC's current position in OLMA?

As of Q3 2026, Vivo Capital, LLC holds 671.84K shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $5.80M, representing 0.66% of its reported portfolio and ranking #34.

Has Vivo Capital, LLC been buying or selling OLMA?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in OLMA. The position peaked in Q4 2023 at 1.87M shares.

Which other funds hold OLMA?

Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.